Healthcare & Life Sciences
Lever Bio
United States
seed
seed
Stage
1
Investors
About
Develops therapeutics that reprogram the solid tumor microenvironment to enhance the efficacy of cancer immunotherapies.
Explore Lever Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.